Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A English

Showing results (361-370 of 391) with videos related to

Pageof 40
Sort By:
Molecular Psychiatry|August 17, 2016
A Phase 1B, randomized, double blind, placebo controlled, multiple-dose escalation study of NSI-189 phosphate, a neurogenic compound, in depressed patientsM Fava, K Johe, L Ereshefsky, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2014
A Phase I, dose-finding study in patients with advanced solid malignancies of the oral γ-secretase inhibitor PF-03084014Wells A Messersmith, Geoffrey I Shapiro, James M Cleary, et al.
The Lancet. Diabetes & Endocrinology|June 16, 2025
Treatments for MEN1-associated endocrine tumours: three systematic reviews and a meta-analysisKatherine A English, Carolina R C Pieterman, Francesca Marini, et al.
Molecular Psychiatry|December 9, 2015
A Phase 1B, randomized, double blind, placebo controlled, multiple-dose escalation study of NSI-189 phosphate, a neurogenic compound, in depressed patientsM Fava, K Johe, L Ereshefsky, et al.
Cell Reports|July 13, 2017
In Vitro Modeling Using Ciliopathy-Patient-Derived Cells Reveals Distinct Cilia Dysfunctions Caused by CEP290 MutationsHiroko Shimada, Quanlong Lu, Christine Insinna-Kettenhofen, et al.
Annual Review of Marine Science|March 31, 2012
Climate change impacts on marine ecosystemsScott C Doney, Mary Ruckelshaus, J Emmett Duffy, et al.
International Journal of Cancer|November 23, 2024
Calcium sensing receptor expression is downregulated in gastroenteropancreatic neuroendocrine tumours via epigenetic mechanismsKatherine A English, Michelle Goldsworthy, Brittannie Willis, et al.
Iscience|February 9, 2024
Selective transcriptomic dysregulation of metabolic pathways in liver and retina by short- and long-term dietary hyperglycemiaAnupam K Mondal, Daniel C Brock, Sheldon Rowan, et al.
The Lancet. Diabetes & Endocrinology|June 16, 2025
Multiple endocrine neoplasia type 1 (MEN1): recommendations and guidelines for best practiceMaria Luisa Brandi, Carolina R C Pieterman, Katherine A English, et al.
Biological Psychiatry|March 18, 2019
Integrated Lipidomics and Proteomics Point to Early Blood-Based Changes in Childhood Preceding Later Development of Psychotic Experiences: Evidence From the Avon Longitudinal Study of Parents and ChildrenFrancisco Madrid-Gambin, Melanie Föcking, Sophie Sabherwal, et al.
Pageof 40

Showing results (361-370 of 391) with videos related to

Sort By:
Pageof 40
Molecular Psychiatry|August 17, 2016
A Phase 1B, randomized, double blind, placebo controlled, multiple-dose escalation study of NSI-189 phosphate, a neurogenic compound, in depressed patientsM Fava, K Johe, L Ereshefsky, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2014
A Phase I, dose-finding study in patients with advanced solid malignancies of the oral γ-secretase inhibitor PF-03084014Wells A Messersmith, Geoffrey I Shapiro, James M Cleary, et al.
The Lancet. Diabetes & Endocrinology|June 16, 2025
Treatments for MEN1-associated endocrine tumours: three systematic reviews and a meta-analysisKatherine A English, Carolina R C Pieterman, Francesca Marini, et al.
Molecular Psychiatry|December 9, 2015
A Phase 1B, randomized, double blind, placebo controlled, multiple-dose escalation study of NSI-189 phosphate, a neurogenic compound, in depressed patientsM Fava, K Johe, L Ereshefsky, et al.
Cell Reports|July 13, 2017
In Vitro Modeling Using Ciliopathy-Patient-Derived Cells Reveals Distinct Cilia Dysfunctions Caused by CEP290 MutationsHiroko Shimada, Quanlong Lu, Christine Insinna-Kettenhofen, et al.
Annual Review of Marine Science|March 31, 2012
Climate change impacts on marine ecosystemsScott C Doney, Mary Ruckelshaus, J Emmett Duffy, et al.
International Journal of Cancer|November 23, 2024
Calcium sensing receptor expression is downregulated in gastroenteropancreatic neuroendocrine tumours via epigenetic mechanismsKatherine A English, Michelle Goldsworthy, Brittannie Willis, et al.
Iscience|February 9, 2024
Selective transcriptomic dysregulation of metabolic pathways in liver and retina by short- and long-term dietary hyperglycemiaAnupam K Mondal, Daniel C Brock, Sheldon Rowan, et al.
The Lancet. Diabetes & Endocrinology|June 16, 2025
Multiple endocrine neoplasia type 1 (MEN1): recommendations and guidelines for best practiceMaria Luisa Brandi, Carolina R C Pieterman, Katherine A English, et al.
Biological Psychiatry|March 18, 2019
Integrated Lipidomics and Proteomics Point to Early Blood-Based Changes in Childhood Preceding Later Development of Psychotic Experiences: Evidence From the Avon Longitudinal Study of Parents and ChildrenFrancisco Madrid-Gambin, Melanie Föcking, Sophie Sabherwal, et al.
Pageof 40